Over the past 12 months, 0 insiders at iTeos Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on ITOS: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 25 | Michel DetheuxChief Executive Officer | SELL | 43.9K | $10.02 | $440K |
| Jun 9, 25 | Michel DetheuxChief Executive Officer | SELL | 43.9K | $10.03 | $440K |
| Jun 6, 25 | Michel DetheuxChief Executive Officer | SELL | 43.9K | $10.21 | $448K |
| Jun 6, 25 | David HallalDirector | SELL | 38.2K | $10.24 | $391K |
| Jun 5, 25 | Michel DetheuxChief Executive Officer | SELL | 43.9K | $10.15 | $445K |
| Jun 5, 25 | David HallalDirector | SELL | 38.2K | $10.15 | $388K |
| Jun 4, 25 | Michel DetheuxChief Executive Officer | SELL | 43.9K | $10.10 | $443K |
| Jun 4, 25 | David HallalDirector | SELL | 38.2K | $10.07 | $385K |
| May 15, 25 | Ecor1 Capital, LlcTenPercentOwner | BUY | 3.30M | $8.00 | $26.4M |
| May 14, 25 | Ecor1 Capital, LlcTenPercentOwner | BUY | 1.66M | $7.41 | $12.3M |
| May 13, 25 | L.p. Mpm Bioventures 2018 (b)Other | SELL | 630.2K | $8.06 | $5.1M |
| May 13, 25 | Mpm Bioimpact LlcOther | SELL | 1.03M | $8.06 | $8.3M |
| May 13, 25 | Mpm Bioventures 2018 Gp LlcOther | SELL | 630.2K | $8.06 | $5.1M |
| Nov 19, 24 | Matthew GallChief Financial Officer | BUY | 5.0K | $7.73 | $39K |
| Oct 12, 23 | Matthew GallChief Financial Officer | BUY | 5.0K | $8.37 | $42K |
| Aug 23, 23 | Aaron I. DavisOther | SELL | 219.6K | $16.87 | $3.7M |
| Jun 9, 22 | David HallalDirector | SELL | 1.2K | $19.51 | $23K |
| Jun 8, 22 | David HallalDirector | SELL | 11.9K | $20.39 | $243K |
| May 11, 22 | Aaron I. DavisDirector | SELL | 337.1K | $18.25 | $6.2M |
| May 10, 22 | Aaron I. DavisDirector | SELL | 95.2K | $25.18 | $2.4M |
| May 9, 22 | Aaron I. DavisDirector | SELL | 200.0K | $23.47 | $4.7M |
| May 2, 22 | Aaron I. DavisDirector | SELL | 92.7K | $27.53 | $2.6M |
| Apr 29, 22 | Aaron I. DavisDirector | SELL | 115.0K | $28.22 | $3.1M |
| Apr 28, 22 | Aaron I. DavisDirector | SELL | 150.0K | $27.40 | $4.1M |
| Apr 18, 22 | Michel DetheuxChief Executive Officer | SELL | 11.5K | $32.64 | $365K |
| Mar 23, 22 | Aaron I. DavisDirector | BUY | 20.0K | $32.85 | $657K |
| Mar 22, 22 | Aaron I. DavisDirector | BUY | 21.3K | $33.43 | $679K |
| Mar 22, 22 | Michel DetheuxChief Executive Officer | SELL | 9.9K | $36.51 | $338K |
| Mar 17, 22 | Boxer Capital, LlcTenPercentOwner | SELL | 575.2K | $35.25 | $20.3M |
| Mar 11, 22 | Joanne Jenkins LagerChief Medical Officer | SELL | 3.5K | $36.01 | $126K |
| Mar 1, 22 | Yvonne McGrathChief Scientific Officer | SELL | 10.0K | $36.76 | $368K |
| Feb 23, 22 | Michel DetheuxChief Executive Officer | SELL | 14.0K | $35.32 | $479K |
| Feb 11, 22 | Joanne Jenkins LagerChief Medical Officer | SELL | 2.0K | $36.27 | $70K |
| Jan 25, 22 | Michel DetheuxChief Executive Officer | SELL | 10.1K | $36.21 | $358K |
| Jan 14, 22 | Joanne Jenkins LagerChief Medical Officer | SELL | 2.8K | $39.58 | $109K |
| Jan 5, 22 | Ansbert GadickeTenPercentOwner | SELL | 30.3K | $42.03 | $1.3M |
| Jan 5, 22 | Mpm Asset Management Investors Bv2018 LlcTenPercentOwner | SELL | 18.1K | $42.03 | $762K |
| Jan 5, 22 | Mpm Bioventures 2018 Gp LlcTenPercentOwner | SELL | 18.1K | $42.03 | $762K |
| Jan 4, 22 | Ansbert GadickeTenPercentOwner | SELL | 158.6K | $46.47 | $6.7M |
| Jan 4, 22 | Mpm Asset Management Investors Bv2018 LlcTenPercentOwner | SELL | 94.7K | $46.47 | $4.0M |
| Jan 4, 22 | Mpm Bioventures 2018 Gp LlcTenPercentOwner | SELL | 94.7K | $46.47 | $4.0M |
| Jan 4, 22 | Mva Investors, LlcTenPercentOwner | SELL | 88.1K | $45.48 | $3.7M |
| Jan 3, 22 | Detlev BiniszkiewiczDirector | SELL | 3.5K | $51.90 | $182K |
| Jan 3, 22 | Joanne Jenkins LagerChief Medical Officer | SELL | 7.0K | $51.90 | $363K |
| Jan 3, 22 | Mva Investors, LlcTenPercentOwner | SELL | 432.9K | $50.63 | $20.6M |
| Dec 27, 21 | Matthew GallChief Financial Officer | SELL | 5.0K | $46.45 | $232K |
| Dec 22, 21 | Michel DetheuxChief Executive Officer | SELL | 9.5K | $45.37 | $431K |
| Dec 21, 21 | Michel DetheuxChief Executive Officer | SELL | 13.6K | $45.06 | $602K |
| Dec 20, 21 | David HallalDirector | SELL | 50.0K | $43.57 | $2.2M |
| Dec 20, 21 | Michel DetheuxChief Executive Officer | SELL | 9.1K | $43.94 | $400K |
Over the past 12 months, insiders at iTeos Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on ITOS, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market ITOS insider purchase in our data was $26.4M by Ecor1 Capital, Llc, TenPercentOwner, filed on May 15, 25.
0 different insiders at iTeos Therapeutics, Inc. filed open-market SEC Form 4 transactions on ITOS over the last 12 months.
InsiderTape plots every ITOS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every iTeos Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →